YopH (residues 164-468) Citations (4)

Originally described in: An open library of human kinase domain constructs for automated bacterial expression.
Albanese SK, Parton DL, Isik M, Rodriguez-Laureano L, Hanson SM, Behr JM, Gradia S, Jeans C, Levinson NM, Seeliger MA, Chodera JD Biochemistry. 2018 Jul 13. doi: 10.1021/acs.biochem.7b01081. PubMed Journal

---

Articles Citing YopH (residues 164-468)

Articles
Methods for the recombinant expression of active tyrosine kinase domains: Guidelines and pitfalls. Diaz Galicia ME, Aldehaiman A, Hong S, Arold ST, Grunberg R. Methods Enzymol. 2019;621:131-152. doi: 10.1016/bs.mie.2019.02.027. Epub 2019 Mar 26. PubMed
De novo design of tyrosine and serine kinase-driven protein switches. Woodall NB, Weinberg Z, Park J, Busch F, Johnson RS, Feldbauer MJ, Murphy M, Ahlrichs M, Yousif I, MacCoss MJ, Wysocki VH, El-Samad H, Baker D. Nat Struct Mol Biol. 2021 Sep;28(9):762-770. doi: 10.1038/s41594-021-00649-8. Epub 2021 Sep 13. PubMed
Mapping the conformational energy landscape of Abl kinase using ClyA nanopore tweezers. Li F, Fahie MA, Gilliam KM, Pham R, Chen M. Nat Commun. 2022 Jun 20;13(1):3541. doi: 10.1038/s41467-022-31215-5. PubMed
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling. Roy MJ, Surudoi MG, Kropp A, Hou J, Dai W, Hardy JM, Liang LY, Cotton TR, Lechtenberg BC, Dite TA, Ma X, Daly RJ, Patel O, Lucet IS. Nat Commun. 2023 Jun 19;14(1):3542. doi: 10.1038/s41467-023-38869-9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.